Graph Representation Learning for Predicting Drug-Target Associations in Complex Human Disease Networks

Authors

  • Myrthe Remmers Department of Computer Science, University of Alabama at Birmingham, Birmingham, AL, USA. Author
  • Galasso Trevisani Department of Computer Science, University of New Hampshire, Durham, NH, USA. Author

Keywords:

graph representation learning; drug-target association; disease networks; network medicine; heterogeneous graphs; calibration

Abstract

Predicting drug-target associations in complex human disease networks requires models that can integrate molecular interaction topology, disease-module structure, and heterogeneous pharmacological evidence without collapsing them into a single similarity score. Existing supervised drug-target interaction models often treat diseases as label contexts rather than as structured network perturbations, which limits their ability to distinguish shared targets from disease-specific vulnerabilities. This manuscript develops a graph representation learning framework that conditions drug-target association scoring on disease-network topology. The framework represents drugs, targets, disease modules, pathways, and anatomical or functional contexts as typed nodes and relations; propagates information through relation-specific message passing; and uses a disease-context gate to modulate target embeddings. A bilinear association head produces calibrated probabilities, while the training objective combines positive-unlabeled learning, relation-aware regularization, and negative sampling that controls for target popularity and literature bias. The contribution is methodological: it specifies how disease modules enter representation learning, how graph topology affects target prioritization, and how evaluation should separate predictive discrimination from mechanistic plausibility. The framework also identifies failure modes that are specific to complex disease networks, including literature-driven edge sparsity, confounding by drug promiscuity, and leakage across disease splits. The resulting design provides a technically coherent basis for prioritizing drug-target associations in network medicine and for interpreting model outputs as evidence-ranked hypotheses rather than validated therapeutic claims.

References

1. Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: A network-based approach to human disease. Nature Reviews Genetics, 12(1), 56–68. https://doi.org/10.1038/nrg2918

2. Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007). The human disease network. Proceedings of the National Academy of Sciences, 104(21), 8685–8690. https://doi.org/10.1073/pnas.0701361104

3. Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabási, A.-L. (2015). Uncovering disease-disease relationships through the incomplete interactome. Science, 347(6224), 1257601. https://doi.org/10.1126/science.1257601

4. Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008). Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 24(13), i232–i240. https://doi.org/10.1093/bioinformatics/btn162

5. Bleakley, K., & Yamanishi, Y. (2009). Supervised prediction of drug-target interactions using bipartite graphs and chemical/genomic spaces. Bioinformatics, 25(18), 2397–2403. https://doi.org/10.1093/bioinformatics/btp400

6. Luo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., & Zeng, J. (2017). A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nature Communications, 8, 573. https://doi.org/10.1038/s41467-017-00680-8

7. Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., Pon, A., Knox, C., & Wilson, M. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. https://doi.org/10.1093/nar/gkx1037

8. Kipf, T. N., & Welling, M. (2017). Semi-supervised classification with graph convolutional networks. International Conference on Learning Representations.

9. Veličković, P., Cucurull, G., Casanova, A., Romero, A., Liò, P., & Bengio, Y. (2018). Graph attention networks. International Conference on Learning Representations.

10. HerbSyner_Finder: a network community-based model for identifying synergistic combinations from herbal medicines and complex systems. Targetome. 2026;2(2):0-0. doi: 10.48130/targetome-0026-001

11. Hamilton, W. L., Ying, R., & Leskovec, J. (2017). Inductive representation learning on large graphs. Advances in Neural Information Processing Systems, 30, 1024–1034.

12. Grover, A., & Leskovec, J. (2016). node2vec: Scalable feature learning for networks. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (pp. 855–864). https://doi.org/10.1145/2939672.2939754

13. Zitnik, M., Agrawal, M., & Leskovec, J. (2018). Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics, 34(13), i457–i466. https://doi.org/10.1093/bioinformatics/bty294

14. Himmelstein, D. S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S. L., Hadley, D., Green, A., Khankhanian, P., & Baranzini, S. E. (2017). Systematic integration of biomedical knowledge prioritizes drugs for repurposing. eLife, 6, e26726. https://doi.org/10.7554/eLife.26726

15. Tsubaki, M., Tomii, K., & Sese, J. (2019). Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences. Bioinformatics, 35(2), 309–318. https://doi.org/10.1093/bioinformatics/bty535

16. Nguyen, T., Le, H., Quinn, T. P., Nguyen, T., Le, T. D., & Venkatesh, S. (2021). GraphDTA: Predicting drug-target binding affinity with graph neural networks. Bioinformatics, 37(8), 1140–1147. https://doi.org/10.1093/bioinformatics/btaa921

17. Chen, R., Liu, X., Jin, S., Lin, J., & Liu, J. (2018). Machine learning for drug-target interaction prediction. Molecules, 23(9), 2208. https://doi.org/10.3390/molecules23092208

18. Zhou, J., Cui, G., Hu, S., Zhang, Z., Yang, C., Liu, Z., Wang, L., Li, C., & Sun, M. (2020). Graph neural networks: A review of methods and applications. AI Open, 1, 57–81. https://doi.org/10.1016/j.aiopen.2021.01.001

19. Wang, Y., You, Z.-H., Yang, S., Yi, H.-C., Chen, Z.-H., & Zhang, K. (2020). A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network. BMC Medical Informatics and Decision Making, 20(Suppl 2), 49. https://doi.org/10.1186/s12911-020-1052-0

20. Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Bork, P., Jensen, L. J., & von Mering, C. (2021). The STRING database in 2021: Customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Research, 49(D1), D605–D612. https://doi.org/10.1093/nar/gkaa1074

Downloads

Published

2026-11-12